Your session is about to expire
← Back to Search
NRCT-101-SR for ADHD
Study Summary
This trial will test a new treatment for adult ADHD to assess effectiveness and safety.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My weight is between 50 and 105 kg, and my lean body mass is 75 kg or less.I have been diagnosed with ADHD according to DSM-5.My family has a history of sudden heart-related deaths or irregular heartbeats.My medication doses have been stable for the last 30 days.My thyroid function is not normal, but I've been on stable thyroid medication for over 3 months.I am not pregnant or breastfeeding.My kidney function is poor, with an eGFR below 40 mL/min/m2.I have a history of serious gut issues like chronic diarrhea or Crohn's disease.You are capable of providing informed consent.I am fluent in English and can read, write, and communicate effectively.I do not have a severe physical disability that affects my ability to complete tests.I do not have any serious illness that could worsen or affect my study participation.I drink more than the specified weekly alcohol limit.I am 18 years old or older.I have never taken ADHD medication or stopped taking it at least 2-3 weeks ago.You have finished at least a decade of formal schooling.I have a history of seizures or tic disorders, but not Tourette's.I have a history of serious heart problems.My ADHD symptoms are severe and haven't improved much since my last check-up.
- Group 1: Matching Placebo
- Group 2: NRCT-101SR
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants still welcome to join the experiment?
"Based on the details recorded on clinicaltrials.gov, this medical trial is not currently accepting patients. The research was initially posted on 1/1/2023 and last updated on 1/4/2023. However, 150 alternative studies are open for recruitment at present moment."
How many medical facilities are participating in this trial's implementation?
"Currently, 6 different medical centres are enrolling patients in this trial. These sites can be found in Lakeland, Maitland and Boston among a few other locations. To lessen the burden of travel if you decide to participate, it would be advantageous to select the closest clinic available."
What goals is this research endeavor attempting to accomplish?
"The principal objective of this 6-week clinical trial is to appraise the fluctuation from baseline in ADHD Investigator Symptom Rating Scale (AISRS). Auxiliary outcomes assessed include revision from Baseline in Hospital Anxiety and Depression Scale (HADS), Adult ADHD Quality of Life scale (AAQoL) and Clinical Global Impression - Severity (CGI-S). The HADS consists of 14 items on a 4-point spectrum, ranging between 0 and 3; it evaluates generalised anxiety using HADSA questions, while measuring anhedonia with its HADS-D component. Similarly, AAQoL comprises"
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger